Ticker Scorecard - ANTX Basics Company: AN2 Therapeutics, Inc. IPO Date: March 25, 2022 Sector: Healthcare Industry: Biotech Market Cap: $33.76M Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 4.27% Avg Daily Range (30 D): $0.03 | 2.32% Avg Daily Range (90 D): $0.03 | 2.75% Institutional Daily Volume Avg Daily Volume: .16M Avg Daily Volume (30 D): .13M Avg Daily Volume (90 D): .36M Trade Size Avg Trade Size (Sh.): 167 Avg Trade Size (Sh.) (30 D): 377 Avg Trade Size (Sh.) (90 D): 400 Institutional Trades Total Inst.Trades: 50 Avg Inst. Trade: $1.92M Avg Inst. Trade (30 D): $.53M Avg Inst. Trade (90 D): $.53M Avg Inst. Trade Volume: .36M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.45M Avg Closing Trade (30 D): $.54M Avg Closing Trade (90 D): $.54M Avg Closing Volume: 225.92K     News May 21, 2024 @ 1:35 PM Down -5.51% in 4 Weeks, Here's Why AN2 Therapeutic... Source: Zacks Equity Research Feb 13, 2024 @ 1:08 PM ZoomInfo Technologies To Rally Around 50%? Here Ar... Source: Avi Kapoor Feb 12, 2024 @ 7:15 PM Nasdaq Edges Lower; ContextLogic Shares Surge Source: Avi Kapoor Feb 12, 2024 @ 6:07 PM Why Big Lots Shares Are Trading Lower By Around 31... Source: Avi Kapoor Feb 12, 2024 @ 5:30 PM Dow Surges Over 150 Points; Gilead Sciences To Acq... Source: Avi Kapoor Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.99 $-.43 $-.48 Diluted EPS $-1.99 $-.43 $-.48 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -60.7M $ -12.75M $ -14.44M Operating Income / Loss $ -67.01M $ -14.01M $ -15.88M Cost of Revenue $ $ $ Net Cash Flow $ .89M $ 6.74M $ 2.08M PE Ratio